Evidence map›Paper›PMID 40575910›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Claudia Palazzolo, Angela Corpolongo, Serena Vita, Alessandra D'Abramo, Gaetano Maffongelli, Patrizia De Marco, Jingjing Lin, Silvia D'Arezzo, Marco Cilliano, Maria Laura Pettinato and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Claudia PalazzoloNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Angela CorpolongoNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Serena VitaNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Alessandra D'AbramoNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Gaetano MaffongelliNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Patrizia De MarcoNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Jingjing LinNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Silvia D'ArezzoNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Marco CillianoSS Malattie Infettive, ASL Gallura, Olbia, Italy.
Maria Laura PettinatoSS Malattie Infettive, ASL Gallura, Olbia, Italy.
Maria Grazia BocciNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.
Emanuele NicastriNational Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Between December 2023 and February 2025, six cases of

Indexed as

AntimalarialsMalaria, FalciparumPlasmodium falciparumTravelAdultFemaleHumansItalyMaleMiddle AgedTanzaniaAntimalarialsItalyMalariamalaria prophylaxisPlasmodium falciparumpre-travel consultationsZanzibar

Identifiers

PMID40575910
PMCPMC12207197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.